Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone liposome in relapsed/refractory PTCL and NK/T-cell lymphoma
CTR20182224Phase 2Active
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Dec 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in peripheral T-cell lymphoma (PTCL), natural killer/T-cell lymphoma (NKTL), angioimmunoblastic T-cell lymphoma (AITL), systemic anaplastic large cell lymphoma (ALCL), anaplastic large cell lymphoma (ALCL), sponsored by CSPC Pharmaceutical Group. Started Dec 2018; status: active.
02
Drugs
mitoxantrone
03
Conditions
peripheral T-cell lymphoma (PTCL)natural killer/T-cell lymphoma (NKTL)angioimmunoblastic T-cell lymphoma (AITL)systemic anaplastic large cell lymphoma (ALCL)anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on CTR20182224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182224.